B-hCD19/hCD20 mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

top

Please input keywords

KR

사회적 책임

합작연구개발

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

동물/세포 모델

Humanized animal models

KO mouse models

Immunodeficient mice/rats

Disease mouse models

Pharmacology service

Therapeutic area

Types of services

유전자 편집

By technologies

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Microbial detection

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

동물/세포 모델

동물/세포모델

Humanized Mouse Models

Humanizad Mouse Models

B-hCD19/hCD20 mice

Strain Name	C57BL/6-Cd19^{tm4(CD19)Bcgen} Ms4a1^{tm2(MS4A1)Bcgen}/Bcgen	Common Name	B-hCD19/hCD20 mice
Background	C57BL/6	Catalog number	113114
Aliases	B4, CVID3; B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7;
NCBI Gene ID	12478, 12482

B-hCD19/hCD20 mice were obtained by mating B-hCD19 mice (112657) and B-hCD20 mice (111231). For validation data of this mouse model, you can refer to the validation data from the related gene humanized mouse models.